OncoMed Pharmaceuticals Inc (NASDAQ:OMED)

3.16
Delayed Data
As of Apr 20
 +0.08 / +2.60%
Today’s Change
1.74
Today|||52-Week Range
5.56
-22.93%
Year-to-Date
No recent news for OncoMed Pharmaceuticals Inc.

Today’s Trading

Previous close3.08
Today’s open3.10
Day’s range2.95 - 3.19
Volume94,784
Average volume (3 months)223,363
Market cap$124.5M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+66.88%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+51.69%
P/E ratioNM
Price/Sales4.04
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SBPHSpring Bank Pharmace...+0.01+0.07%
MNOVMediciNova Inc-0.36-3.11%
CKPTCheckpoint Therapeut...+0.11+2.74%
OCULOcular Therapeutix I...-0.03-0.46%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$38.2M
Annual profit (last year)-$39.1M
Net profit margin-102.38%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Lewicki
Chief Financial &
Accounting Officer
Yvonne Li
Corporate headquarters
Redwood City, California

Forecasts